Explore evidence

10 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 10% had occult HBV infection.

Côte d'Ivoirehépatite B · VIH/sidapublished 2010Antiviral therapyeurope_pmcdocument of 7 observations

2,646 person-yearsParticipants in the Temprano ANRS 12136 posttrial phase were followed for 2646 person-years.

Côte d'IvoireVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 6 observations

0.56 probabilityThe 36-month probability of immunovirologic success was 0.56 in patients with a medication possession ratio (MPR) below 90%.

Côte d'IvoireVIH/sidapublished 2009AIDS research and human retroviruseseurope_pmcdocument of 2 observations

46 patients46 patients had not been treated (74.2%).

Côte d'IvoireVIH/sidaobserved 1999–2006published 2010Le Mali medicaleurope_pmcdocument of 17 observations

36 yearsThe mean age of 491 adult HIV patients was 36 ± 8.68 years.

Côte d'IvoireVIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations

22 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 22% had signs of cured HBV infection.

Côte d'Ivoirehépatite B · VIH/sidapublished 2010Antiviral therapyeurope_pmcdocument of 7 observations

87 %In the per-protocol analysis, HIV RNA less than 50 copies/ml at 24 weeks was observed in 64 of 77 (87%) patients in the FZD arms.

Côte d'IvoireVIH/sidapublished 2017AIDS (London, England)europe_pmcdocument of 7 observations

102 cells/mm³The median CD4 count was 102 cells/mm³.

Côte d'IvoireVIH/sidapublished 2024Open forum infectious diseaseseurope_pmcdocument of 9 observations

166 cells/mm³The median CD4 count at ART initiation was 166 cells/mm³ among HIV-2 infected patients.

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

8.1 %The frequency of thymidine analog mutations increased from 8.1% at month 12 to 14.7% at month 24 after ART initiation.

Côte d'IvoireVIH/sidapublished 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 11 observations

24.2 %Among 273 included patients, 66 (24.2%) experienced non-clinical indicators relevant to HIV infection risk.

Côte d'IvoireVIH/sidaobserved 2013–2014published 2017PloS oneeurope_pmcdocument of 5 observations

3.7 log10_c/mLThe median baseline viral load was 3.7 log10 copies/mL.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

387 cells/μLThe median CD4 count was 387 cells/μL.

Côte d'IvoireVIH/sidapublished 2022HIV medicineeurope_pmcdocument of 6 observations

11.5 per_100_person-yearsThe incidence of first serious event among HIV-infected adults receiving antiretroviral treatment was 11.5 per 100 person-years overall.

Côte d'IvoireVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1186/1471-2334-13-607

16.5 %Pretreatment HIV drug resistance (PDR) frequency was 16.5% in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublished 2018Journal of Antimicrobial ChemotherapyOpenAlexdocument of 9 observationsDOI 10.1093/jac/dky443

42.4 yearsAt ART initiation, the median age of dually seropositive patients was 42.4 years.

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

5.1 %Of the 312 patients initially classified as HIV-2, 16 (5.1%) were reclassified as HIV-1.

Côte d'IvoireVIH/sidaobserved 2012published 2014Journal of the International AIDS Societyeurope_pmcdocument of 8 observations

100 %Detectable HCV RNA was identified in 100% of anti-HCV positive HIV-1-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

12.3 %HIV overall prevalence was 12.3% among the 1,017 cancer cases included.

Côte d'Ivoirecancer (non précisé) · VIH/sidapublished 2012PloS oneeurope_pmcdocument of 7 observationsDOI 10.1371/journal.pone.0048108

10 per_100_person_yearsAfter a median 2.0 year follow-up, the incidence rate of serious HIV-related events was 10.0 per 100 person-years among HIV mono-infected patients.

Côte d'IvoireVIH/sidapublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 7 observationsDOI 10.4269/ajtmh.16-1016

57,833 peopleIn January 2009, a total of 57,833 people living with HIV/AIDS received antiretroviral therapy and follow-up at 274 HIV care centers in Côte d'Ivoire.

Côte d'IvoireVIH/sidaobserved January 2009published 2009Medecine tropicale : revue du Corps de sante colonialeurope_pmcdocument of 5 observations

30.5 %The main clinical side-effect was peripheral neuropathy (30.5%).

Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

8.1 per_100_person-yearsThe incidence of attrition among HIV-infected adults receiving antiretroviral treatment was 8.1 per 100 person-years.

Côte d'IvoireVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1186/1471-2334-13-607

30 %Among HIV-infected adults interviewed, 30% had no stable partnership.

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 5 observations

8.9 %Among adolescent girls living with HIV in Côte d'Ivoire, 8.9% reported parents' refusal as a barrier to HPV vaccination.

Côte d'Ivoireinfection à HPV · VIH/sidaobserved 2024–2025HAL · Unilimdocument of 69 observations